Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 7231301000001113 | Brexidol 20mg tablet | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 8660301000001119 | Brexidol 20mg tablet | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brexidol 20mg tablet | Is a | Piroxicam-beta-cyclodextrin 191.3mg tablet | false | Inferred relationship | Existential restriction modifier | ||
| Brexidol 20mg tablet | Availability | Product is currently available | false | Additional relationship | Existential restriction modifier | ||
| Brexidol 20mg tablet | NHS prescribing status | NHS prescribable | false | Additional relationship | Existential restriction modifier | ||
| Brexidol 20mg tablet | Legal category | Prescription Only Medicine | false | Additional relationship | Existential restriction modifier | ||
| Brexidol 20mg tablet | CSM recommendation to report adverse reactions | Report all adverse reactions to the CSM | false | Additional relationship | Existential restriction modifier | ||
| Brexidol 20mg tablet | Product name type | Brand name | false | Additional relationship | Existential restriction modifier | ||
| Brexidol 20mg tablet | Has active ingredient | Piroxicam | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR